MEETINGS - BVMed (German medical device industry association will hold its Innovationskongress (Germany) September 2001:
This article was originally published in Clinica
Executive Summary
The German medical device industry association industry (BVMed) will hold its Innovationskongress on September 26 2001 at the Hilton Hotel, Berlin. Are medical advances being hampered by government policy and what are the possible and affordable cardiology treatments of the future? are two of the questions that will be addressed by a panoply of German healthcare experts, including Professors Ludger Seipel, chief medical officer at the Tubingen Eberhard-Karl University, and Roland Hetzer, CMO at Berlin's Deutsches Herzzentrum. Details from: BVMed (now relocated to Berlin) on tel: +49 (0)30 24 62 550; fax: +49 (0)30 24 62 5599; email: [email protected] www.bvmed.de
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.